PCM
CRDF icon

Princeton Capital Management’s Cardiff Oncology CRDF Stock Holding History

Princeton Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-141
Closed – – 120
2019
Q3 		$0 Hold
141
– – ﹤0.01% 246
2019
Q2 		$0 Sell
141
-99
-41% -$317 ﹤0.01% 247
2019
Q1 		$1K Buy
240
+2
+0.8% +$7 ﹤0.01% 234
2018
Q4 		$1K Hold
238
– – ﹤0.01% 251
2018
Q3 		$1K Hold
238
– – ﹤0.01% 256
2018
Q2 		$1K Buy
238
+1
+0.4% +$17 ﹤0.01% 286
2018
Q1 		$6K Hold
237
– – ﹤0.01% 259
2017
Q4 		$5K Buy
+237
New +$10.5K ﹤0.01% 100

Other funds holding CRDF

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LWA
LWS Wealth Advisors Basking Ridge, New Jersey $266M AUM 12.97% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Princeton Capital Management's CRDF Position: Q4 2019 in Review

Princeton Capital Management sold out of Cardiff Oncology (CRDF) in Q4 2019, closing a stake of 141 shares.

Princeton Capital Management first reported a position in CRDF in Q4 2017 and held it in 8 quarters. The position peaked at $6K in Q1 2018. 19 funds tracked by Wall St. Rank hold CRDF as of Q4 2019.

  • Princeton Capital Management reported no remaining Cardiff Oncology position as of Q4 2019 after selling out during the quarter.
  • Princeton Capital Management sold 141 Cardiff Oncology shares in Q4 2019.
  • Princeton Capital Management first reported a position in Cardiff Oncology in Q4 2017 and held it in 8 quarters.
  • Princeton Capital Management's Cardiff Oncology position peaked at $6K in Q1 2018.
  • 19 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2019.

Based on Princeton Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.